Basal Cell Carcinoma Bcc clinical trials

Explore recruiting basal cell carcinoma bcc clinical trials.

Recruiting basal cell carcinoma bcc studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Basal Cell Carcinoma Bcc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2 controlled randomized study of the efficacy of L19IL2 or L19TNF or L19IL2/L19TNF intralesional injections for the treatment of locally advanced basal cell carcinoma patients.

Greece, Italy, Germany, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Open-label, Phase 2 study of Intratumoral Vidutolimod (CMP-001) in Combination with Intravenous Cemiplimab in Subjects with Selected Types of Advanced or Metastatic Cancer

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase II study of intratumoral administration of L19IL2/L19TNF in non-melanoma skin cancer patients with presence of injectable lesions.

Poland, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

This is clinical study to test, for the first time in people, the safety (any good or bad effects), how long the drug can stay in the body and if it can control the disease of people diagnosed with advanced cancer that has not responded to treatment, has returned after it has been treated, or cannot be treated by surgery, drugs, or any other known treatments.

Italy, Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase II study of L19IL2/L19TNF in patients with skin cancers amenable to intralesional treatment.

Spain, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Basal Cell Carcinoma Bcc trials by city

Basal Cell Carcinoma Bcc clinical trials

Recruiting basal cell carcinoma bcc studies right now

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

Study of Intralesional FLD-103 in Subjects With Basal Cell Carcinoma (BCC)

Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment

R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors

Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Also recruiting in Europe

A Phase 2 controlled randomized study of the efficacy of L19IL2 or L19TNF or L19IL2/L19TNF intralesional injections for the treatment of locally advanced basal cell carcinoma patients.

A Multicenter, Open-label, Phase 2 study of Intratumoral Vidutolimod (CMP-001) in Combination with Intravenous Cemiplimab in Subjects with Selected Types of Advanced or Metastatic Cancer

A Phase II study of intratumoral administration of L19IL2/L19TNF in non-melanoma skin cancer patients with presence of injectable lesions.

A Phase II study of L19IL2/L19TNF in patients with skin cancers amenable to intralesional treatment.

Basal Cell Carcinoma Bcc trials by city

Other conditions